Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 903
Recruiting: 504
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 501–550 of 644 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02843945	Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source	recruiting	Phase 1 / Phase 2	80	CivaTech OncologyINDUSTRY	1	Jun 17, 2025	clinicaltrials
NCT07007832	Bile Omics for Diagnosing Indeterminate Biliary Strictures	recruiting	—	260	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Jun 11, 2025